
AVIDITY PARTNERS MANAGEMENT LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | CNTX | 5.50M | $8.09M |
![]() | IMUX | 4.70M | $2.51M |
![]() | DNTH | 2.10M | $86.71M |
![]() | SCYX | 2.08M | $1.32M |
![]() | CGON | 1.47M | $61.15M |
![]() | JBIO | 1.40M | $21.61M |
![]() | ORKA | 660K | $20.02M |
![]() | TEVA | 417K | $13.02M |
![]() | KVUE | 233K | $4.02M |
![]() | PHAT | 206K | $3.42M |
![]() | PFE | 204K | $5.07M |
![]() | ACHC | 169K | $2.40M |
![]() | ELVN | 140K | $2.16M |
![]() | KPTI | 135K | $990.41K |
![]() | CNC | 119K | $4.91M |
![]() | BSX | 115K | $10.92M |
![]() | MDT | 108K | $10.34M |
![]() | ACAD | 107K | $2.86M |
![]() | GMAB | 92K | $2.83M |
![]() | NVO | 67K | $3.42M |

Context Therapeutics Inc.
CNTX
Shares Held
5.50M
Value
$8.09M

Immunic, Inc.
IMUX
Shares Held
4.70M
Value
$2.51M

Dianthus Therapeutics, Inc.
DNTH
Shares Held
2.10M
Value
$86.71M

SCYNEXIS, Inc.
SCYX
Shares Held
2.08M
Value
$1.32M

CG Oncology, Inc. Common stock
CGON
Shares Held
1.47M
Value
$61.15M

Jade Biosciences, Inc.
JBIO
Shares Held
1.40M
Value
$21.61M

Oruka Therapeutics, Inc.
ORKA
Shares Held
660K
Value
$20.02M

Teva Pharmaceutical Industries Limited
TEVA
Shares Held
417K
Value
$13.02M

Kenvue Inc.
KVUE
Shares Held
233K
Value
$4.02M

Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
206K
Value
$3.42M

Pfizer Inc.
PFE
Shares Held
204K
Value
$5.07M

Acadia Healthcare Company, Inc.
ACHC
Shares Held
169K
Value
$2.40M

Enliven Therapeutics, Inc.
ELVN
Shares Held
140K
Value
$2.16M

Karyopharm Therapeutics Inc.
KPTI
Shares Held
135K
Value
$990.41K

Centene Corporation
CNC
Shares Held
119K
Value
$4.91M

Boston Scientific Corporation
BSX
Shares Held
115K
Value
$10.92M

Medtronic plc
MDT
Shares Held
108K
Value
$10.34M

ACADIA Pharmaceuticals Inc.
ACAD
Shares Held
107K
Value
$2.86M

Genmab A/S
GMAB
Shares Held
92K
Value
$2.83M

Novo Nordisk A/S
NVO
Shares Held
67K
Value
$3.42M
